Form D · Other Health Care
GLYSENS Inc
San Diego, CA · CIK 0001662530
Offering snapshot reported Jan 4, 2016 · SEC filing
- Reported sold
- $20M Offering amount: $21M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $30K Reported outside-investor minimum
- First sale
- Dec 21, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 4, 2016 | Initial | $20,000,030 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-254377
Source: Form D, filed Jan 4, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Knox Bell | Executive |
| Robert L. Engler | Director |
| Adam E. Fine | Director |
| Samuel V. Goekjian | Director |
| Orville G. Kolterman | Director |
| Joseph Y. Lucisano | Director, Executive |
| William H. Markle | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
6450 Lusk Blvd., Suite E 109
San Diego, CA, 92121
San Diego, CA, 92121